Technical Analysis for AGL - Angle Plc

Grade Last Price % Change Price Change
grade A 81.0 5.19% 4.00
AGL closed up 5.19 percent on Monday, September 16, 2019, on approximately normal volume. The bulls were able to push the stock to a new 52-week high. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical AGL trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Wide Range Bar Range Expansion 0.00%
New 52 Week High Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Multiple of Ten Bullish Other 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Cup with Handle Other 5.19%
Doji - Bearish? Reversal 5.19%

Older signals for AGL ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
ANGLE plc is a holding company. The Company's principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health. Its Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. The resulting liquid biopsy (blood test) enables the detection and investigation of mutations in the patient's cancer for personalized cancer care. The harvested CTCs have a range of applications, including diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring.
Medicine Medical Specialties Cancer Clinical Medicine Drug Development Oncology Medical Diagnostic
Is AGL a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 82.7
52 Week Low 38.0
Average Volume 324,890
200-Day Moving Average 61.1426
50-Day Moving Average 71.832
20-Day Moving Average 71.19
10-Day Moving Average 72.32
Average True Range 2.6369
ADX 24.45
+DI 38.8148
-DI 9.8461
Chandelier Exit (Long, 3 ATRs ) 74.7893
Chandelier Exit (Short, 3 ATRs ) 75.4707
Upper Bollinger Band 78.1705
Lower Bollinger Band 64.2095
Percent B (%b) 1.2
BandWidth 19.6109
MACD Line 1.2856
MACD Signal Line 0.0615
MACD Histogram 1.2241
Fundamentals Value
Market Cap 47.68 Million
Num Shares 589 Thousand
EPS -0.08
Price-to-Earnings (P/E) Ratio -1012.50
Price-to-Sales 0.00
Price-to-Book 383.15
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 89.55
Resistance 3 (R3) 89.17 85.93 88.13
Resistance 2 (R2) 85.93 83.76 86.13 87.65
Resistance 1 (R1) 83.47 82.41 84.70 83.85 87.17
Pivot Point 80.23 80.23 80.85 80.43 80.23
Support 1 (S1) 77.77 78.06 79.00 78.15 74.83
Support 2 (S2) 74.53 76.71 74.73 74.35
Support 3 (S3) 72.07 74.53 73.88
Support 4 (S4) 72.45